Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2

• Auteurs principaux: Xiang Tong (Auteur), Shijie Zhang (Auteur), Dongguang Wang (Auteur), Li Zhang (Auteur), Jizheng Huang (Auteur), Tianli Zhang (Auteur), Hong Fan (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Pulmonary fibrosis (PF) is a chronic and progressive process of tissue repair. Azithromycin (AZM) may be beneficial for the treatment of PF because AZM has anti-inflammatory and immune regulatory roles and inhibits remodeling, but the mechanism is not entirely clear. In this study, we established a...